HLS Therapeutics (74D.F) Q3 2024 Earnings

Aug 8Confirmed
Q2 2024
Q3 2024
-0.18
-0.16
-0.15
-0.14

Details

Expected EPS
-0.13944695033
Actual EPS
-0.1648818
Surprise EPS
-0.03
Surprise Percent
-18.24%

Description

⁨HLS Therapeutics⁩ (⁦74D.F⁩) has reported earnings of ⁦-0.1648818⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts